跳至主要内容
临床试验/CTRI/2024/02/063259
CTRI/2024/02/063259招募中4 期

Stellate Ganglion Block in the Management of Treatment Resistant Anxiety Disorders: a randomized controlled trial. - NI

Sri Madhusudan Sai Institute of Medical Sciences and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adults with treatment resistant anxiety disorder who score ?10 on GAD-7 questionnaire and are willing to consent.

排除标准

  • 1.Participants unwilling to provide consent
  • 2.Participants with known history of drug allergy to bupivacaine, lidocaine or depot methylprednisolone
  • 3.Recent myocardial infarction
  • 4.Patients on anti-coagulants or dual anti-platelet drugs
  • 5.Glaucoma
  • 6.Severe COPD
  • 7.Cardiac conduction block

研究者

发起方
Sri Madhusudan Sai Institute of Medical Sciences and Research

相似试验